Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis
- 20 October 2015
- journal article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 20 (11), 1868-1871
- https://doi.org/10.1111/1756-185x.12776
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Successful treatment with humanized anti–interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean feverModern Rheumatology, 2015
- Myositis in a patient with familial Mediterranean fever and spondyloarthritis successfully treated with anakinraJoint Bone Spine, 2013
- Familial Mediterranean Fever in JapanMedicine, 2012
- Effects of Anti-Tumor Necrosis Factor Agents for Familial Mediterranean Fever Patients With Chronic Arthritis and/or Sacroiliitis Who Were Resistant to Colchicine TreatmentJCR: Journal of Clinical Rheumatology, 2011
- Histologic Signs of Inflammatory Myopathy in Familial Mediterranean FeverJCR: Journal of Clinical Rheumatology, 2006
- Continuity of cytokine activation in patients with familial Mediterranean feverClinical Rheumatology, 2004
- The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filamentsBlood, 2001
- The clinical patterns of myalgia in children with familial Mediterranean feverSeminars in Arthritis and Rheumatism, 2000
- Criteria for the diagnosis of familial mediterranean feverArthritis & Rheumatism, 1997
- Polymyositis and DermatomyositisThe New England Journal of Medicine, 1975